Scarica l'app Stockscreener
5.46
1.30%
0.07
Dopo l'orario di chiusura:
5.41
-0.05
-0.92%
Precedente Chiudi:
$5.39
Aprire:
$5.39
Volume 24 ore:
28,082
Relative Volume:
0.06
Capitalizzazione di mercato:
$69.77M
Reddito:
$134.00K
Utile/perdita netta:
$-33.51M
Rapporto P/E:
-1.7023
EPS:
-3.2074
Flusso di cassa netto:
$-18.15M
1 W Prestazione:
-4.71%
1M Prestazione:
-9.90%
6M Prestazione:
+5.20%
1 anno Prestazione:
+49.59%
Intervallo 1D:
$5.29
$5.4665
Intervallo di 1 settimana:
$5.29
$5.96
Portata 52W:
$3.25
$13.50
Clene Inc Stock (CLNN) Company Profile
Nome
Clene Inc
Settore
Industria
Telefono
801-676-9695
Indirizzo
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ARGX, RVMD, ALNY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
5.46 | 68.88M | 134.00K | -33.51M | -18.15M | -3.2074 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-02 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-28 | Iniziato | Oppenheimer | Outperform |
Clene Inc Borsa (CLNN) Ultime notizie
Best Nanotechnology Stocks Worth WatchingJuly 27th - MarketBeat
Clene Inc. (CLNN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clene Inc. (CLNN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clene Inc. (CLNN) Balance Sheet - TradingKey
Top Nanotechnology Stocks To Keep An Eye OnJuly 26th - MarketBeat
Clene Inc. (CLNN) Income Statement - TradingKey
CLNN|Clene Inc.|Price:5.480|Chg%:+0.090 - TradingKey
Clene Inc. (CLNN) Slips 1.64% as Stock Consolidates Near Key SupportParabolic SAR - dars.gov.et
CLNN Options Chain — NASDAQ:CLNN - TradingView
TradingKey - TradingKey
CLNN Options Volatility — NASDAQ:CLNN - TradingView
CLNN Stock Falls After Roth Labels Accelerated Approval For ALS Drug A ‘Long Shot’ - Stocktwits
Nanotechnology Stocks To Watch NowJuly 24th - MarketBeat
Clene Inc. (CLNN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Best Nanotechnology Stocks To ResearchJuly 23rd - MarketBeat
Top Nanotechnology Stocks To ResearchJuly 22nd - MarketBeat
Nanotechnology Stocks To Keep An Eye OnJuly 21st - MarketBeat
When Will Clene Inc. (NASDAQ:CLNN) Breakeven? - simplywall.st
Top Nanotechnology Stocks To Watch NowJuly 20th - MarketBeat
Clene (CLNN) Proxy filing Summary - Quartr
CLNN Stock Rises 8% – Here’s What The FDA Update Means For Clene’s ALS Treatment - Stocktwits
Clene (CLNN) Q1 2026 earnings summary - Quartr
Best Nanotechnology Stocks To Keep An Eye OnJuly 15th - MarketBeat
Enterprise value to EBIT forward of Clene Inc. – NASDAQ:CLNN - TradingView
Enterprise value to revenue forward of Clene Inc – FWB:84C0 - TradingView
Clene Inc. (CLNN) Edges Higher, Testing Key Resistance at $6.58Bollinger Expansion - dars.gov.et
Top Nanotechnology Stocks Worth WatchingJuly 11th - MarketBeat
Clene (CLNN) Q2 Virtual Investor Summit Event earnings summary - Quartr
Clene Inc. (CLNN) reports Q1 loss, misses revenue estimates - MSN
CLNN Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ReactionCost Structure Review - dars.gov.et
Enterprise value to EBIT forward of Clene Inc – FWB:84C0 - TradingView
Promising Nanotechnology Stocks To Keep An Eye OnJuly 9th - MarketBeat
Clene (CLNN) Registration Filing Summary - Quartr
Clene (CLNN) Emerging Growth Conference 92 Summary - Quartr
Clene (CLNN) Study Update Summary - Quartr
Clene (CLNN) Q4 2025 earnings summary - Quartr
Clene (CLNN) Emerging Growth Virtual Conference Summary - Quartr
Clene (CLNN) Emerging Growth Conference 89 Summary - Quartr
Clene (CLNN) 37th Annual ROTH Conference Summary - Quartr
Clene Inc. (CLNN) Q1 2026 Earnings: EPS Beat of 58.42% Surprises Estimates Amid Pre-Revenue PhaseFull Year Guidance - dars.gov.et
CLNN News | CLENE INC (NASDAQ:CLNN) - ChartMill
Clene Inc. (CLNN) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesStrong Earnings Momentum - dars.gov.et
Clene Company Profile & Introduction - Moomoo
CLNN Q1 2026 Earnings: Narrowed Loss Surprises Analysts Amidst Operational FocusAnnual Financial Report - dars.gov.et
Clene Inc.(NasdaqCM: CLNN) added to Russell Microcap Value Benchmark Index - marketscreener.com
Clene Inc.(NasdaqCM: CLNN) added to Russell Microcap Index - marketscreener.com
Clene Inc.(NasdaqCM: CLNN) added to Russell 3000E Index - marketscreener.com
Clene Inc.(NasdaqCM: CLNN) added to Russell 3000E Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Clene Inc. – NASDAQ:CLNN - TradingView
Price to earnings forward of Clene Inc. – NASDAQ:CLNN - TradingView
Price to earnings forward of Clene Inc. – BOATS:CLNN - TradingView
Clene Inc Azioni (CLNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):